Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ZOM

Zomedica Corp

Dec 12 • 02:32PM ET

0.1245

Dollar change +0.0001
Percentage change 0.08	%

Healthcare • Medical Devices • USA • AMEX

Peers: IDXX ELAN CAH WOOF QDEL PETS ONVO BARK HEPA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.06	Insider Own	1.76%	Shs Outstand	979.95M	Perf Week	-1.03%
Market Cap	122.01M	Forward P/E	-	EPS next Y	-0.03	Insider Trans	14.24%	Shs Float	962.66M	Perf Month	-11.07%
Income	-62.19M	PEG	-	EPS next Q	-0.01	Inst Own	8.26%	Short Float	4.60%	Perf Quarter	-5.75%
Sales	26.73M	P/S	4.56	EPS this Y	-37.14%	Inst Trans	-3.83%	Short Ratio	9.13	Perf Half Y	-19.99%
Book/sh	0.21	P/B	0.60	EPS next Y	37.50%	ROA	-25.43%	Short Interest	44.26M	Perf Year	-22.91%
Cash/sh	0.08	P/C	1.59	EPS next 5Y	-	ROE	-26.82%	52W Range	0.12 - 0.23	Perf YTD	-37.81%
Dividend Est.	-	P/FCF	-	EPS past 5Y	27.70%	ROI	-30.44%	52W High	-45.51%	Beta	1.06
Dividend TTM	-	Quick Ratio	10.15	Sales past 5Y	78.21%	Gross Margin	47.66%	52W Low	6.41%	ATR (14)	0.01
Dividend Ex-Date	-	Current Ratio	10.82	EPS Y/Y TTM	-317.76%	Oper. Margin	-143.14%	RSI (14)	44.46	Volatility	3.61% 5.62%
Employees	144	Debt/Eq	0.01	Sales Y/Y TTM	11.33%	Profit Margin	-232.70%	Recom	1.00	Target Price	0.25
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	-1260.00%	Payout	-	Rel Volume	0.83	Prev Close	0.12
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	10.24%	Earnings	Nov 07 AMC	Avg Volume	4.85M	Price	0.12
SMA20	-3.21%	SMA50	-1.97%	SMA200	-10.81%	Trades		Volume	3,151,545	Change	0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-23	Initiated	Dawson James	Buy	$6

Nov-27-24 06:30AM	Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 (ACCESSWIRE)
Nov-14-24 06:30AM	Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform (ACCESSWIRE) -6.69%
Nov-12-24 06:30AM	Noble Capital Markets Initiates Equity Research Coverage on Zomedica (ACCESSWIRE) +14.38%
Nov-08-24 02:02PM	Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... (GuruFocus.com)
06:30AM	Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 (ACCESSWIRE)
04:25PM	Loading…
Nov-07-24 04:25PM	Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth (ACCESSWIRE)
Oct-24-24 06:30AM	Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform (ACCESSWIRE)
Oct-23-24 07:20PM	Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET (ACCESSWIRE)
Oct-15-24 06:30AM	Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference (ACCESSWIRE)
Oct-09-24 06:24PM	Zomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue Challenges (GuruFocus.com)
Oct-03-24 06:30AM	Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe (ACCESSWIRE)
Sep-11-24 06:30AM	Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota (ACCESSWIRE)
Sep-05-24 06:30AM	Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities (ACCESSWIRE)
Aug-29-24 06:30AM	Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product (ACCESSWIRE)
Aug-22-24 06:30AM	Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System (ACCESSWIRE)
06:30AM	Loading…
Aug-20-24 06:30AM	Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference (ACCESSWIRE)
Aug-14-24 04:05PM	Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth (ACCESSWIRE) -5.54%
06:30AM	Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America (ACCESSWIRE)
Aug-01-24 06:30AM	Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET (ACCESSWIRE)
Jul-17-24 06:30AM	The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEA (ACCESSWIRE)
Jul-09-24 06:30AM	Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets (ACCESSWIRE)
Jul-01-24 06:30AM	US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians (ACCESSWIRE)
Jun-27-24 06:30AM	Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform (ACCESSWIRE) +5.81%
Jun-25-24 06:30AM	Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark (ACCESSWIRE)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-10-24 06:30AM	Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024 (ACCESSWIRE)
Jun-06-24 06:30AM	Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference (ACCESSWIRE)
Jun-04-24 06:30AM	Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels (ACCESSWIRE)
May-29-24 06:30AM	Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay (ACCESSWIRE)
May-23-24 06:30AM	Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy (ACCESSWIRE)
06:30AM	Loading…
May-21-24 06:30AM	Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 (ACCESSWIRE)
May-15-24 06:30AM	Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform (ACCESSWIRE) +15.81%
May-10-24 04:02PM	Zomedica Corp (ZOM) Q1 2024 Earnings: Revenue Climbs Amidst Rising Costs, Aligns with Analyst ... (GuruFocus.com) -14.35%
May-09-24 04:15PM	Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity (ACCESSWIRE)
May-08-24 06:30AM	Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024 (ACCESSWIRE)
May-06-24 06:30AM	Zomedica Expands International Reach with CE Certification for VetGuardian(R) System (ACCESSWIRE) +11.57%
May-02-24 06:30AM	Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform (ACCESSWIRE)
Apr-30-24 06:30AM	Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET (ACCESSWIRE)
Apr-09-24 06:30AM	Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 (ACCESSWIRE)
Apr-01-24 04:05PM	Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity (ACCESSWIRE)
Mar-20-24 06:30AM	Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET (ACCESSWIRE)
Mar-14-24 06:30AM	Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform (ACCESSWIRE)
Mar-13-24 04:45PM	Zomedica Provides NYSE American Listing Update (ACCESSWIRE) +6.76%
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
06:30AM	Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences (ACCESSWIRE)
Mar-07-24 06:30AM	Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs (ACCESSWIRE)
Mar-05-24 06:30AM	Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024 (ACCESSWIRE)
Feb-08-24 06:30AM	Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences (ACCESSWIRE)
Feb-06-24 04:30PM	Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) (ACCESSWIRE)
06:30AM	Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET (ACCESSWIRE)
Jan-31-24 06:30AM	Open Letter to Zomedica Shareholders from your Chief Executive Officer (ACCESSWIRE)
Jan-30-24 06:30AM	Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference (ACCESSWIRE)
Jan-25-24 04:35PM	Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split (ACCESSWIRE)
Jan-17-24 04:00PM	Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split") (ACCESSWIRE) -11.31%
Jan-10-24 06:30AM	Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024 (ACCESSWIRE)
Jan-04-24 06:30AM	Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel "X-Trode" Handpiece (ACCESSWIRE)
Dec-18-23 06:30AM	Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease (ACCESSWIRE) +13.53%
Dec-06-23 06:30AM	Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners (ACCESSWIRE)
Nov-28-23 06:30AM	Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference (ACCESSWIRE)
Nov-20-23 06:30AM	Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference (ACCESSWIRE)
Nov-13-23 04:20PM	Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies (ACCESSWIRE)
Nov-02-23 06:30AM	Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET (ACCESSWIRE) +6.93%
Oct-11-23 06:30AM	Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference (ACCESSWIRE)
Oct-05-23 06:30AM	Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development (ACCESSWIRE)
Sep-27-23 06:30AM	Zomedica, Inc. to Present at the LD Micro Main Event XVI (Newsfile)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-14-23 06:30AM	Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushings Disease in Horses (ACCESSWIRE)
Sep-13-23 04:30PM	Zomedica Provides Corporate Update (ACCESSWIRE)
Sep-05-23 04:30PM	Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio (ACCESSWIRE)
Aug-31-23 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-10-23 04:25PM	Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity (ACCESSWIRE)
Aug-08-23 06:30AM	Zomedica to Present at Sidoti Virtual Investor Conference August 16-17 (ACCESSWIRE)
Aug-04-23 06:30AM	Zomedica to Host Second Quarter Financial Results Call on August 10 (ACCESSWIRE)
Aug-02-23 12:45PM	RedChip Launches 'Small Stocks, Big Money' Podcast (ACCESSWIRE)
Jun-09-23 07:30AM	Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services (ACCESSWIRE)
May-12-23 04:15PM	Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference (ACCESSWIRE) -6.98%
May-11-23 04:25PM	Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity (ACCESSWIRE)
May-08-23 06:30AM	Zomedica Exercises Option to Acquire Structured Monitoring Products (ACCESSWIRE)
May-02-23 06:30AM	Zomedica to Host First Quarter Financial Results Call on May 11 (ACCESSWIRE)
Apr-18-23 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Mar-31-23 09:00AM	Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Mar-17-23 06:30AM	Zomedica Appoints New Chief Financial Officer (ACCESSWIRE) -18.31%
Mar-15-23 04:45PM	Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth (ACCESSWIRE)
Mar-08-23 06:30AM	Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15 (ACCESSWIRE)
Feb-09-23 06:30AM	Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022 (ACCESSWIRE)
Feb-08-23 04:15PM	Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Jan-25-23 08:00AM	RedChip CEO Dave Gentry Invited to Join Forbes Business Council (ACCESSWIRE)
Jan-24-23 06:00AM	Zomedica to Participate in the Lytham Partners Investor Select Conference (ACCESSWIRE)
Jan-18-23 06:00AM	Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies (ACCESSWIRE) -8.52%
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) +17.01%
06:00AM	Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors (ACCESSWIRE)
Jan-11-23 06:00AM	Zomedica to Present at Sidoti Virtual Investor Conference January 18-19 (ACCESSWIRE)
Dec-15-22 06:30AM	Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans (ACCESSWIRE)
Nov-14-22 04:20PM	Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities (ACCESSWIRE) -7.23%
Oct-18-22 06:30AM	Zomedica to Present at LD Micro Main Event XV Conference (ACCESSWIRE)
Sep-28-22 06:30AM	Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference (ACCESSWIRE)
Sep-13-22 06:30AM	Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform (ACCESSWIRE)
Sep-12-22 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Sep-06-22 06:30AM	Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association (ACCESSWIRE) -9.88%

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blair Anthony K	COO	Nov 08 '24	Buy	0.12	150,000	18,450	400,000	Nov 13 04:07 PM
POWERS JOHNNY D	Director	Nov 11 '24	Buy	0.12	100,000	12,100	2,425,000	Nov 12 09:00 AM
HEATON LARRY C II	CEO	Nov 11 '24	Buy	0.12	100,000	12,200	500,000	Nov 12 06:11 AM
Klass Russell Kevin	Vice President of Sales	Nov 11 '24	Buy	0.12	500,000	60,290	1,500,050	Nov 12 06:11 AM
HEATON LARRY C II	CEO	Sep 05 '24	Buy	0.12	100,000	12,500	400,000	Sep 05 02:30 PM
POWERS JOHNNY D	Director	Aug 28 '24	Buy	0.13	100,000	12,900	2,325,000	Aug 28 04:19 PM
Blair Anthony K	COO	Aug 20 '24	Buy	0.14	100,000	14,200	250,000	Aug 20 03:55 PM
Klass Russell Kevin	Vice President of Sales	Jun 12 '24	Buy	0.16	299,993	46,529	2,000,050	Jun 13 06:32 PM
Klass Russell Kevin	Vice President of Sales	Jun 11 '24	Buy	0.15	500,000	75,100	1,700,057	Jun 12 04:15 PM
Klass Russell Kevin	Vice President of Sales	Jun 10 '24	Buy	0.15	200,007	29,941	1,200,057	Jun 12 04:15 PM
Donato Peter	Chief Financial Officer	Jun 10 '24	Buy	0.15	25,000	3,798	25,000	Jun 11 04:15 PM
POWERS JOHNNY D	Director	May 17 '24	Buy	0.17	100,000	17,450	2,225,000	May 17 03:08 PM
POWERS JOHNNY D	Director	May 16 '24	Buy	0.18	25,000	4,600	2,125,000	May 17 10:08 AM
POWERS JOHNNY D	Director	May 14 '24	Buy	0.14	50,000	6,981	2,100,000	May 15 04:30 PM
POWERS JOHNNY D	Director	May 13 '24	Buy	0.14	100,000	14,000	2,050,000	May 14 04:31 PM
Blair Anthony K	COO	May 13 '24	Buy	0.14	150,000	21,000	150,000	May 14 04:31 PM
HEATON LARRY C II	CEO	May 13 '24	Buy	0.14	100,000	14,200	300,000	May 13 05:07 PM
POWERS JOHNNY D	Director	Dec 15 '23	Buy	0.17	100,000	16,500	1,950	Dec 18 09:20 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZOM

Zomedica Corp

Upgrade your FINVIZ experience